Go Deep
JFL Life Sciences Limited
JFL Life Sciences Limited Score & Ratio Trend
Not enough history yet — this builds up over time as the company refreshes monthly. Check back in a few weeks.
JFL Life Sciences Limited Quarterly Results
| Line Item | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | 630,544,000.0 | 117,321,000.0 |
| Net Profit | 16,587,000.0 | 829,000.0 |
| EPS | 0.5 | 0.0 |
JFL Life Sciences Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,313,826,000.0 | 820,423,000.0 | 465,479,000.0 | 428,284,000.0 | — |
| Net Profit | 64,010,000.0 | 41,577,000.0 | 33,004,000.0 | 28,096,000.0 | — |
| EPS | — | 1.2 | 1.0 | 0.9 | 0.8 |
JFL Life Sciences Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,062,461,000.0 | 719,140,000.0 | 567,103,000.0 | 515,208,000.0 | — |
| Total Liabilities | 603,769,000.0 | 324,586,000.0 | 211,349,000.0 | 192,532,000.0 | — |
| Total Equity | 458,692,000.0 | 394,554,000.0 | 355,754,000.0 | 322,675,000.0 | — |
JFL Life Sciences Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 0.8%Receivables 50.1%Inventory 32.5%Fixed assets (tangible) 13.7%Other assets 2.8%
How it's funded — Mar 2026
Short-term debt 14.0%Long-term debt 6.5%Payables 27.6%Other liabilities 8.8%Shareholders' equity 43.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.9 | 0.0 | 0.0 | 0.1 |
| Receivables | 53.3 | 34.9 | 25.8 | 24.6 |
| Inventory | 34.5 | 23.2 | 15.8 | 12.7 |
| Fixed assets (tangible) | 14.5 | 12.2 | 12.8 | 7.2 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.1 | 0.0 | 0.0 | 0.0 |
| Other assets | 3.0 | 1.5 | 2.2 | 7.0 |
| Liabilities & equity | ||||
| Short-term debt | 14.8 | 10.2 | 5.3 | 6.4 |
| Long-term debt | 6.9 | 0.4 | 0.4 | 0.8 |
| Payables | 29.3 | 17.8 | 12.5 | 9.9 |
| Other liabilities | 9.4 | 4.1 | 2.9 | 2.2 |
| Shareholders' equity | 45.9 | 39.5 | 35.6 | 32.3 |
| Net tangible assets | 45.9 | 39.5 | 35.6 | 32.3 |
JFL Life Sciences Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -43,308,000.0 | -35,572,000.0 | 84,084,000.0 | -90,691,000.0 | — |
| Investing Activities | -39,448,000.0 | 152,000.0 | -60,866,000.0 | 8,710,000.0 | — |
| Financing Activities | 91,046,000.0 | 35,417,000.0 | -23,469,000.0 | 80,717,000.0 | — |